Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development

Butyrylcholinesterase (BChE) is a plasma enzyme that hydrolyzes ghrelin and bioactive esters, suggesting a role in modulating metabolism. Serum BChE is reduced in cancer patients. In prostate cancer (PC), the down-regulation is associated with disease recurrence. Nonetheless, how BChE is expressed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yan, Chow, Mathilda Jing, Kapoor, Anil, Mei, Wenjuan, Jiang, Yanzhi, Yan, Judy, De Melo, Jason, Seliman, Maryam, Yang, Huixiang, Cutz, Jean-Claude, Bonert, Michael, Major, Pierre, Tang, Damu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031255/
https://www.ncbi.nlm.nih.gov/pubmed/29966864
http://dx.doi.org/10.1016/j.tranon.2018.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031255/
https://www.ncbi.nlm.nih.gov/pubmed/29966864
http://dx.doi.org/10.1016/j.tranon.2018.06.003

Ejemplares similares